Objectives. To demonstrate safety and efficacy of using different generations of softer
Amplatzer™ devices for ventricular septal defect (VSD) closure to avoid serious …

Earlier attempts at percutaneous closure of perimembranous ventricular septal defects (Pm
VSDs) were abandoned because of incidence of heart block likely as a result of device …

Objectives To describe the immediate and midterm results of a modified method for
transcatheter closure of perimembranous ventricular septal defects (pmVSDs). Background …

Objective To analyze feasibility of closing perimembranous ventricular septal defect
(pmVSD) with different devices by percutaneous approach and determining initial 1‐year …

Background: Perimembranous ventricular septal defect (VSD) is the most common
congenital heart defect. Percutaneous transcatheter closure of VSD is one of the greatest …

Objectives: We sought to analyze safety, efficacy, and follow-up results of percutaneous
closure of perimembranous ventricular septal defects (pmVSD). Background: Results of …

Long term follow up studies have shown that transcatheter closure of perimembranous
Ventricular Septal Defect (PmVSD) can be done safely and successfully. One of the most …

Although effective, transcatheter closure of perimembranous ventricular septal defects
(pmVSD) with the Amplatzer Membranous VSD Occluder (AGA Medical Corporation, MN) …

The isolated perimembranous ventricular septal defect is one of the most common
congenital cardiac malformations. Although surgery has been performed and has a low …

Objective To show that transcatheter closure of perimembranous ventricular septal defect
(PMVSD) with the Amplatzer ductal occluder (ADO, AGA Medical Corp, Plymouth …